More Immutep Ltd news Immutep LtdASX: IMM Phase II study for eftilagimod alpha in COVID-19 advances Jan 27, 2021 at 3:20 AM UTC · Issued by Immutep Ltd As issuedPlain English Immutep Ltd has released a press release. View Attachment
